Transaction #2862 · Form 4 · 0001453687-25-000112
Cartesian Therapeutics, Inc. · Stock award · Employee Stock Option (right to buy)
Cartesian Therapeutics, Inc. · Transacted October 27, 2025 · Filed October 28, 2025
What does this filing report?
An SEC Form 4 filing for Cartesian Therapeutics, Inc. records a stock award involving Employee Stock Option (right to buy) on October 27, 2025. The reported quantity was 50,000. The filing date is October 28, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Cartesian Therapeutics, Inc.
- Company CIK
- 0001453687
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 50,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 50,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 28, 2025, 4:05 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Seymour June Ann ↗
Chief Accounting Officer
CIK 0002093716
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 50,000
- Conversion / exercise price
- 8.85
- Exercise date
- Not reported
- Expiration date
- October 27, 2035
Filing footnotes & remarks
- F1
- This option vests as to 25% on October 27, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on October 27, 2029.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.